916442-69-8Relevant academic research and scientific papers
ANTAGONISTS OF PGD2 RECEPTORS
-
Page/Page column 76, (2009/06/27)
Described herein are compounds and pharmaceutical compositions containing such compounds that antagonize the PGD2 activated chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2). Also described herein are methods of using such CRTH2 antagonists, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2 mediated conditions or diseases.
Novel 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators
-
Page/Page column 17, (2010/11/27)
The present invention is directed to novel 3-spirocyclic indolyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the ORL-1 receptor.
